RMD is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of RMD shares has decreased $12.63 since the market last closed. This is a 4.87% ...

Chief Strategy Officer Kylie Canaday [Image courtesy of Resmed] Resmed (NYSE: RMD) + announced today that it appointed Kylie Canaday as its new chief strategy officer (CSO). Canaday’s appointment goes ...

Resmed (NYSE: RMD) + shares are down a bit today, even though second-quarter results came in ahead of the consensus forecast. Shares of RMD were down more than 2% to $251.41 apiece in morning trading ...

Provides digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease or COPD, and other chronic diseases.

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, ...

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing ...

Abstract: Being able to build a map of the environment and to simultaneously localize within this map is an essential skill for mobile robots navigating in unknown environments in absence of external ...